Showing results (2081-2090 of 2,418) with videos related to

Sort By:
Pageof 242
European Journal of Haematology|April 4, 2017
Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and JAK inhibitors era?Elsa Lestang, Pierre Peterlin, Yannick Le Bris, et al.
Annales De Pathologie|March 18, 2014
[The RENAPE network: towards a new healthcare organization for the treatment of rare tumors of the peritoneum. Description of the network and role of the pathologists]Laurent Villeneuve, Sylvie Isaac, Olivier Glehen, et al.
Nature Communications|September 26, 2022
Respiratory loss during late-growing season determines the net carbon dioxide sink in northern permafrost regionsZhihua Liu, John S Kimball, Ashley P Ballantyne, et al.
Transplantation|July 17, 2012
Is ASCT with TBI superior to ASCT without TBI in mantle cell lymphoma patients?Pierre Peterlin, Christophe Leux, Thomas Gastinne, et al.
Blood Advances|September 8, 2021
Activation status dictates the function of unlicensed natural killer cells in mice and humansEthan G Aguilar, Cordelia Dunai, Sean J Judge, et al.
Blood Advances|November 9, 2022
Outcomes of subsequent neoplasms after umbilical cord blood transplantation in EuropeHanadi Rafii, Annalisa Ruggeri, Chantal Kenzey, et al.
Nature Communications|November 25, 2025
Immunological surveillance against cancer across mammalsOrsolya Vincze, Piotr Minias, Alexandre Corthay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2014
Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single centerM Loirat, P Chevallier, C Leux, et al.
Bone Marrow Transplantation|June 29, 2023
Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)Enrico Maffini, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Haematologica|July 21, 2018
Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL groupLionel Adès, Xavier Thomas, Agnes Guerci Bresler, et al.
Pageof 242